Retatrutide is a newly developed drug that acts as a potent GLP-1 receptor agonist. This breakthrough treatment holds significant promise for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials have demonstrat